COSMOS Pharmaceutical Corporation (3349.T)

Home
3349.T
Financials

7149 (JPY) • At close November 12, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004
Revenue Numbers are in millions	964,989	827,697	755,414	726,424	684,403	611,137	557,999	502,732	447,273	408,466	371,825	329,313	279,021	237,174	205,387	177,756	148,244	125,846	105,046	78,651
Cost of Revenue Numbers are in millions	794,951	658,979	603,966	581,313	549,419	489,353	447,681	402,688	360,420	330,391	301,268	267,527	226,035	191,672	165,323	141,741	115,547	97,491	81,761	60,937
Gross Profit Numbers are in millions	170,038	168,718	151,448	145,111	134,984	121,784	110,318	100,044	86,853	78,075	70,557	61,786	52,986	45,502	40,064	36,015	32,697	28,355	23,285	17,714
Gross Profit Ratio Numbers are in millions	0.176	0.204	0.2	0.2	0.197	0.199	0.198	0.199	0.194	0.191	0.19	0.188	0.19	0.192	0.195	0.203	0.221	0.225	0.222	0.225
Reseach & Development Expenses Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
General & Administrative Expenses Numbers are in millions	116	128	127	129	127	128	129	118	117	116	119	127	0	0	0	0	3,978	4,603	3,879	3,106
Selling & Marketing Expenses Numbers are in millions	1,812	1,648	1,632	2,784	4,266	3,771	1,836	1,815	1,688	1,781	1,645	1,297	0	0	0	0	1,224	929	896	764
SG&A Numbers are in millions	138,536	122,807	107,756	99,163	93,347	85,050	76,680	68,097	59,442	54,095	48,517	42,087	0	0	0	0	5,202	5,532	4,775	3,870
Other Expenses Numbers are in millions	2,853	2,960	3,066	2,741	2,546	2,521	2,515	2,366	2,043	1,615	1,438	1,212	1,160	1,037	1,095	802	688	652	476	291
Operating Expenses Numbers are in millions	138,536	138,589	121,651	111,964	105,890	97,008	87,568	77,806	68,205	60,993	53,849	46,256	39,657	35,462	32,321	30,576	27,889	24,592	19,877	15,455
Operating Income Numbers are in millions	31,502	30,128	29,796	33,147	29,094	24,775	22,749	22,237	18,648	17,080	16,707	15,529	13,329	10,040	7,743	5,439	4,808	3,763	3,408	2,259
Operating Income Ratio Numbers are in millions	0.033	0.036	0.039	0.046	0.043	0.041	0.041	0.044	0.042	0.042	0.045	0.047	0.048	0.042	0.038	0.031	0.032	0.03	0.032	0.029
Total Other Income Expenses Net Numbers are in millions	2,217	2,643	3,250	5,448	1,308	2,363	2,418	3,499	1,848	2,339	1,708	1,123	1,069	529	1,012	-113	-677	558	311	143
Income Before Tax Numbers are in millions	33,719	32,773	33,048	38,596	30,402	27,139	25,167	25,737	20,496	19,420	18,416	16,652	14,398	10,569	8,755	5,326	4,131	4,321	3,719	2,402
Income Before Tax Ratio Numbers are in millions	0.035	0.04	0.044	0.053	0.044	0.044	0.045	0.051	0.046	0.048	0.05	0.051	0.052	0.045	0.043	0.03	0.028	0.034	0.035	0.031
Income Tax Expense Numbers are in millions	9,265	8,975	9,892	11,439	8,967	7,954	7,534	7,522	8,061	7,725	7,815	7,255	6,661	4,831	4,043	2,484	1,957	2,021	1,775	1,142
Net Income Numbers are in millions	24,454	23,797	23,155	27,156	21,435	19,185	17,633	18,215	12,435	11,694	10,600	9,396	7,737	5,737	4,712	2,841	2,173	2,299	1,944	1,259
Net Income Ratio Numbers are in millions	0.025	0.029	0.031	0.037	0.031	0.031	0.032	0.036	0.028	0.029	0.029	0.029	0.028	0.024	0.023	0.016	0.015	0.018	0.019	0.016
EPS Numbers are in millions	308.61	300.48	292.37	342.89	270.65	242.24	222.64	229.99	157.01	147.65	133.84	237.28	195.39	144.9	119	71.76	54.49	57.48	51.03	74.79
EPS Diluted Numbers are in millions	308.61	300.48	292.37	342.89	270.65	242.24	222.64	229.99	157.01	147.65	133.84	237.28	195.39	144.9	119	71.76	54.49	57.48	51.03	74.79
EBITDA Numbers are in millions	51,426	50,503	48,023	49,730	45,266	40,327	37,226	35,399	30,368	26,424	23,846	21,090	17,701	13,548	10,798	7,770	6,610	5,321	4,562	3,000
EBITDA Ratio Numbers are in millions	0.053	0.061	0.064	0.068	0.066	0.066	0.067	0.07	0.068	0.065	0.064	0.064	0.063	0.057	0.053	0.044	0.045	0.042	0.043	0.038

COSMOS Pharmaceutical Corporation

TSE:3349.T Add to watchlist

TSE:3349.T